Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib.

Current oncology (Toronto, Ont.)·2018

Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims.

Epidemiology and infection·2017

The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.

Leukemia·2017

Myelination, oligodendrocytes, and serious mental illness.

Glia·2014

Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.

Alimentary pharmacology & therapeutics·2014

Continuing education in psychotherapy as a method to attract and involve voluntary faculty in an academic department of psychiatry.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014

See all related articles

Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients

Related Experiment Videos

Related Concept Videos

Related Articles